Cumberland Pharmaceuticals CPIX Operating Lease Liability Payments - 2028 (Lessee)

Operating Lease Liability Payments - 2028 (Lessee) at other companies

PTH

Pelthos Therapeutics Inc.PTHS

——

BridgeBio PharmaBBIO

——

Mirum Pharmaceuticals, Inc.MIRM

——

West Pharmaceutical ServicesWST

——

Other financials

Income statement

See full

Revenue$9.1M-22.0%

Gross profit$7.2M-30.0%

Operating income-$3.1M-342%

Net income-$3.3M-362%

EPS (diluted)-$0.22-375%

Balance sheet

See full

Cash & equivalents$11.0M-27.1%

Total debt$4.8M-7.1%

Total equity$21.6M-24.5%

Total assets$71.0M+1.5%

Cash flow

See full

Operating cash flow$387.0K-90.1%

CapEx--100%

Free cash flow$387.0K-89.9%

Valuation

See full

Market cap$97.09M+138%

Enterprise value$90.91M+207%

P/S2.3×+1.3×

Profitability

See full

Gross margin82.9%-1.4pp

Operating margin-17.2%-125pp

Net margin-17.6%-103pp

FCF margin3.3%—

Returns & leverage

See full

Return on equity-29.4%-86.3pp

Debt / equity0.2×0.0×

Current ratio1×-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's operating lease liability payments - 2028 (lessee).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cumberland Pharmaceuticals's operating lease liability payments - 2028 (lessee)?: Cumberland Pharmaceuticals (CPIX) reported operating lease liability payments - 2028 (lessee) of $667.05K in Q1 2026.
How has Cumberland Pharmaceuticals's operating lease liability payments - 2028 (lessee) changed year-over-year?: Cumberland Pharmaceuticals's operating lease liability payments - 2028 (lessee) increased by 2.5% year-over-year, from $650.77K to $667.05K.